Metraipolis › archive › dc_fce6a2f3f22d
Design and In Vitro Evaluation of Cyclodextrin-Functionalized Albumin Nanoparticles for Intranasal Carbamazepine Brain Delivery — Europe PMC PMID:41900817
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41900817
- DOI
- 10.3390/pharmaceutics18030331
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T01:00:43.034Z
- SHA-256 of the archived text
2985ec8865c7a2e1860cb238291c2a6584d427c775c0afe5d7c87a64b2d4af07- Stable URL of this page
https://metraipolis.com/documento/dc_fce6a2f3f22d
How to cite
Design and In Vitro Evaluation of Cyclodextrin-Functionalized Albumin Nanoparticles for Intranasal Carbamazepine Brain Delivery — Europe PMC PMID:41900817 — Europe PMC (en), https://europepmc.org/article/MED/41900817 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fce6a2f3f22d (Metraipolis archive dc_fce6a2f3f22d, sha256 2985ec8865c7a2e1860cb238291c2a6584d427c775c0afe5d7c87a64b2d4af07)
BibTeX
@misc{dcfce6a2f3f22d,
title = {Design and In Vitro Evaluation of Cyclodextrin-Functionalized Albumin Nanoparticles for Intranasal Carbamazepine Brain Delivery — Europe PMC PMID:41900817},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41900817},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fce6a2f3f22d; sha256 2985ec8865c7a2e1860cb238291c2a6584d427c775c0afe5d7c87a64b2d4af07},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41900817. Agents can read the archived copy with the MCP tool read_document.